Showing results 45 to 56 of 56
< previous
Issue Date | Title | Author(s) |
2019-12-01 | Re-defining moral distress: A systematic review and critical re-appraisal of the argument-based bioethics literature | Sanderson, C; Sheahan, L; Kochovska, S; Luckett, T; Parker, D; Butow, P; Agar, M |
2022-10 | Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study. | Best, MC; Bartley, N; Napier, CE; Fisher, A; Ballinger, ML; Thomas, DM; Goldstein, D; Tucker, K; Biesecker, BB; Butow, P |
2022-02-14 | Staff perspectives on the feasibility of a clinical pathway for anxiety and depression in cancer care, and mid-implementation adaptations. | Butow, P; Shepherd, HL; Cuddy, J; Rankin, N; Harris, M; He, S; Grimison, P; Girgis, A; Faris, M; ADAPT Program Group,; Shaw, J |
2018-04-01 | A systematic review of quantitative observational studies investigating psychological distress in testicular cancer survivors | Smith, A; Rutherford, C; Butow, P; Olver, I; Luckett, T; Grimison, P; Toner, G; Stockler, M; King, M |
2020-07-29 | The value of real-world testing: a qualitative feasibility study to explore staff and organisational barriers and strategies to support implementation of a clinical pathway for the management of anxiety and depression in adult cancer patients. | Geerligs, L; Shepherd, HL; Rankin, NM; Masya, L; Shaw, JM; Price, MA; Dhillon, H; Dolan, C; Prest, G; ADAPT Program Group; Butow, P |
2021-09-14 | Uptake of an online psychological therapy program (iCanADAPT-Early) when implemented within a clinical pathway in cancer care centres. | Davies, F; Harris, M; Shaw, J; Butow, P; Newby, J; Murphy, M; Kirsten, L; ADAPT Program Group,; Shepherd, HL |
2023-06 | Vaccine hesitancy in cancer patients: A rapid review. | Butow, P; Shaw, J; Bartley, N; Milch, V; Sathiaraj, R; Turnbull, S; Der Vartanian, C |
2022-10 | Validation of the Knowledge of Genome Sequencing (KOGS) scale in cancer patients. | Butow, P; Napier, C; Campbell, R; Bartley, N; Best, M; Ballinger, ML |
2022-07 | Validation of the multidimensional impact of Cancer Risk Assessment Questionnaire to assess impact of waiting for genome sequencing results. | Best, M; Napier, C; Schlub, T; Bartley, N; Biesecker, B; Ballinger, M; Butow, P |
2022-02 | Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study. | Butow, P; Davies, G; Napier, CE; Bartley, N; Ballinger, ML; Biesecker, B; Juraskova, I; Meiser, B; Schlub, T; Thomas, DM; Goldstein, D; Best, MC; Members of the PiGeOn Project, |
2020-10-23 | What factors influence organisational readiness for change? Implementation of the Australian clinical pathway for the screening, assessment and management of anxiety and depression in adult cancer patients (ADAPT CP). | Geerligs, L; Shepherd, HL; Butow, P; Shaw, J; Masya, L; Cuddy, J; ADAPT Program Group; Rankin, NM |
2020-02 | Who should access germline genome sequencing? A mixed methods study of patient views. | Best, MC; Butow, P; Jacobs, C; Savard, J; Biesecker, B; Ballinger, ML; Bartley, N; Davies, G; Napier, CE; Smit, AK; Thomas, DM; Newson, AJ; Members of the PiGeOn Project |